Results Brainstorm Cell Therapeutics Inc.
-
Brainstorm Cell Therapeutics Inc.
Quarterly Report for Quarter Ending June 30, 2025 (Form 10-Q)
8/14
-
Brainstorm Cell Therapeutics Inc.
Registration Withdrawal (Form RW)
7/22
-
Brainstorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB (Form 8-K)
7/17
-
Brainstorm Cell Therapeutics Inc.
Initial Registration Statement for Employee Benefit Plan (Form S-8)
7/3
-
Brainstorm Cell Therapeutics Inc.
Registration Statement - Specified Transactions (Form S-3)
6/25
-
Brainstorm Cell Therapeutics Inc.
Proxy Results, Management Change/Compensation (Form 8-K)
6/25
-
Brainstorm Cell Therapeutics Inc.
Additional Proxy Soliciting Materials (Form DEFA14A)
5/16
-
Brainstorm Cell Therapeutics Inc.
Proxy Statement (Form DEF 14A)
5/16
-
Brainstorm Cell Therapeutics Inc.
Quarterly Report for Quarter Ending March 31, 2025 (Form 10-Q)
5/15
-
Brainstorm Cell Therapeutics Inc.
Preliminary Proxy Statement (Form PRE 14A)
5/6